Marie Dray,
MBA
President, International Regulatory Affairs Group LLC
Marie is President, International Regulatory Affairs Group, providing consultation on government policies and product registration strategies. She has been a member of DIA since 1982 and has served two terms on DIA’s Board of Directors, as President as well as leading the Governance and Strategic Planning Committees. Marie is co-founder of the Washington Regulatory Liaison Group, representing industry in trade group initiatives and meetings of special interest groups. She began her professional career as a bacteriologist and hospital administrator and has an MBA in Management of Science, Technology and Innovation. Marie was awarded DIA’s Founder’s Award in 2012.
Fellows of DIA
-
PhD •Chair, Fellows of DIA
President, Japan Self-Medication Industry -
-
JD • President, B-Henry & Associates -
MD, PhD • Pharmacovigilance Expert -
MD • Professor of Clinical Pharmacology, St. Vincent's Hospital -
MBA • President, International Regulatory Affairs Group LLC -
MPH, PhD • Global Chief, Sci Affairs; Sr VP, Head, Center for Advanced Evidence Generation
IQVIA -
PhD • Senior Advisor, Strategic Programs,Center for Drug Evaluation and Research, US Food and Drug Administration -
MD • Senior VP, Chief Medical Officer, Director, Corporate Medical Affairs HQ, Eisai Co., Ltd. -
MBA • Chairman, CISCRP; Director of Sponsored Research, Tufts Center For the Study of Drug Development -
PhD • Corporate Vice President
PAREXEL International -
MD • Senior Vice-President, Industrie Sante -
MD • Deputy Director, FDA Liaison to the EMA, Office of International Programs, OC -
MD • Deputy Director, Integrated Delivery, and Lead for Global Regulatory Systems Initiatives
Bill and Melinda Gates Foundation -
MD, JD • Senior Vice President, Head of Global Regulatory Affairs and Clinical Safety, Merck & Co., Inc. -
MS • Representative, NM Consulting -
PhD • Advisor, Digital Channels and eCapabilities, Eli Lilly and Company -
MD • Chief Medical Officer & EVP, Horizon Pharma, Inc. -
DVM, MBA • Director Biopeople, University of Copenhagen -
PhD • Professor and Director, Institute of Drug Regulatory Science, Shenyang Pharmaceutical University, Venture Partner, Lilly Asia Ventures